Promega Gets Damages Appeal All Wrong, Life Tech Says

Law360 (August 17, 2018, 9:19 PM EDT) -- Promega Corp.'s cert petition seeking additional damages from patent litigation it won over genetic-testing kits focuses on a question that has nothing to do with the actual case, Life Technologies Corp. said in urging the justices to reject it.

While Promega's June petition for a writ of certiorari frames the appeal as a question over when to raise new trial arguments, Life Tech on Wednesday argued that the company "misconstrues the [Federal Circuit's] ruling." The circuit court had refused to grant separate domestic and international damages because Promega actively pursued the case with a worldwide "all-or-nothing damages strategy," not because the question...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!